Search for: "In Re: Schering Plough Corp."
Results 41 - 60
of 74
Sort by Relevance
|
Sort by Date
21 Apr 2010, 12:08 pm
” Schering-Plough Healthcare Products, Inc. v. [read post]
8 Apr 2010, 9:48 am
In re Seroquel Products Liability Litigation, 601 F. [read post]
7 Apr 2010, 9:14 am
Last year, we had Schering-Plough Corp. v. [read post]
12 Mar 2010, 6:48 am
See In re Schering Plough Corp. [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
25 Jan 2010, 5:00 am
Pa. 1989); In re Bexar County Health Facility Development Corp. [read post]
24 Dec 2009, 11:32 am
In re Medtronic, Inc. [read post]
8 Dec 2009, 7:00 pm
EVP and general counsel, Schering-Plough. [read post]
9 Nov 2009, 6:01 am
"They're drivers that knowingly speed. [read post]
19 Oct 2009, 4:30 am
” In re Schering-Plough Corp. [read post]
13 Aug 2009, 9:19 am
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
23 Jul 2009, 3:15 am
We wouldn't base a motion solely on Actimmune, but with Pennsylvania Employees as the lead case, Actimmune is useful supporting precedent.Another candidate for best supporting actor in this area is In re Schering-Plough Corp. [read post]
13 Jul 2009, 9:28 pm
A tip of the old cyberhat - and not for the first time - to Alan Modlinger at Lowenstein Sandler for passing along to us the latest good news on the off-label promotion front - dismissal (with leave to replead under Twombly) in In re Schering-Plough Corp. [read post]
25 Jun 2009, 4:29 am
Genzyme Corp., 2008 WL 2940811 (N.D. [read post]
12 Jun 2009, 12:10 pm
Schering-Plough Corp., No. 05-273, 2006 WL 1358441 (U.S. [read post]
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
3 Apr 2009, 7:23 pm
Cinram International Inc (Property, intangible) USPTO rules for Smith & Nephew in suture patent fight with Arthrex (Law360) USPTO issues mixed decision in re-examination of patent at the centre of battle between Widevine and Verimatrix (Law360) Supreme Court asked to expand defences to patent infringement: IGT v Aristocrat Tech of Australia (on petition for certiorari) (Patently-O) CAFC to hear oral argument in Erbe Elektromedizin GmbH v ITC on 3 April (ITC 337 Law Blog) Tafas v… [read post]
